USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TOLEROGENICS, INC.
Address:
20 NORTH WACKER
SUITE 1201
CHICAGO, IL 60606-
Phone:
N/A
URL:
N/A
EIN:
120837666
DUNS:
803391247
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $192,679.00 1

Award List:

Use of Bispecific Antibody for Treating Non-obese Diabetes

Award Year / Program / Phase:
2011 / STTR / Phase I
Award Amount:
$192,679.00
Agency:
HHS
Principal Investigator:
Bellur S. Prabhakar – 312-996-4945
Research Institution:
UNIVERSITY OF ILLINOIS AT CHICAGO
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Activation of mature T lymphocytes is a multi-step process requiring both Ag-specific triggering of the TCR complex and co-stimulation mediated through the CD28-CD80/CD86 pathway. CTLA-4 is a critical inhibitor of T cell activation as evidenced by the lethal… More